Active Ingredient(s): Polidocanol
FDA Approved: * November 25, 2013
Pharm Company: * PROVENSIS LTD
Category: Blood Vessels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Varithena Overview

Polidocanol is a local anaesthetic and antipruritic component of ointments and bath additives. It relieves itching caused by eczema and dry skin.[1] It has also been used to treat varicose veins,[2] hemangiomas, and vascular malformations.[3] It is formed by the ethoxylation of dodecanol. Sclerotherapy Polidocanol is also used as a sclerosant, an irritant injected to treat varicose veins, under the trade names Asclera, Aethoxysklerol[...

Read more Varithena Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Varithena Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 1%
  • Solution: 10mg/2ml (5mg/ml), 180mg/18ml (10mg/ml), 20mg/2ml (10mg/ml), 77.5mg/7.75ml (10mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Varithena: (4 results)

Sorted by National Drug Code
  • 60635-107 VarithenaVarithena Kit by Biocompatibles, Inc.
  • 60635-111 VarithenaVarithena Kit by Biocompatibles, Inc.
  • 60635-118 Varithena Kit by Biocompatibles, Inc.
  • 60635-133 Varithena Kit by Biocompatibles, Inc.

Other drugs which contain Polidocanol or a similar ingredient: (2 results)